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The predominant manifestation of Leber hereditary optic neuropathy (LHON) is a sudden and 
usually severe bilateral loss of central vision, most often in the mid-20s, that is due to a degeneration 
of the ganglion cell layer and optic nerve. LHON is an inherited form of blindness in which a 
mutation in the mitochondrial genome (mtDNA) is the primary etiological event. More than 95 % of 
the LHON pedigrees in peoples of Northern European descent harbor one of the three 
mitochondrial mutations at nucleotides 3460, 11778 and 14484, although there are other l~are 
primary mutations. In addition, there may be mtDNA mutations that have a secondary etiological 
role. The penetrance of the optic neuropathy is incomplete in LHON families, and males are 
affected much more often then females. The incomplete penetrance indicates that secondary 
etiological factors are necessary for the development of the optic neuropathy, although they are 
poorly understood at the present time. Several types of studies suggest hat optic nerve function in 
LHON patients is impaired in the presymptomatic phase, probably as a result of a mitochondrial 
respiratory chain abnormality, although visual acuity is not compromised. In some family 
members, the presence of secondary etiological factors triggers a wave of optic nerve dysfunctien in 
which vision is lost (the acute phase). Depending upon the particular primary LHON mutation that 
the patient carries, a variable proportion of the dysfunctional ganglion cells and optic nerve axons 
die during the atrophic phase, probably through an apoptotic pathway. In 11778 LHON patients, 
retinal ganglion cell degeneration occurs almost without exception, and recovery of vision is 
extremely rare. In contrast, activation of the cell death pathway is less frequent, or less extensive, in 
14484 LHON patients and there is often a substantial recovery of vision. 
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INTRODUCTION 
In 1871, Theodor Leber published the first detailed 
description of an inherited form of blindness that has 
been eponymously designated Leber hereditary optic 
neuropathy (LHON). LHON is most generally described 
as a bilateral, acute, or sub-acute, loss of central vision in 
otherwise healthy young adults, predominately males. It 
was first observed by Leber, and subsequently confirmed 
in numerous tudies (Bell, 1931; Lundsgard, 1944; van 
Senus, 1963; Seedorff, 1970; Nikoskelainen et al., 1987; 
Mackey & Buttery, 1992), that the risk of vision loss in 
LHON families is inherited exclusively from the mother, 
irrespective of whether or not she is visually affected. It is 
now recognized that this pattern of maternal inheritance 
indicates that the primary etiologic event in LHON is a 
mutation within the mitochondrial genome, the small 
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DNA molecule (<17000 basepairs) that encodes 13 
protein subunits of the respiratory chairL complexes 
(Anderson et al., 1981). A number of mitochondrial 
genetic diseases have been identified uring the last few 
years, LHON being the most prevalent, most of which are 
associated with neurological abnormalities [reviewed in 
Johns (1995); Wallace (1995)]. 
A second interesting feature of LHON is the specificity 
of its neuropathology. The loss of vision in LHON 
patients is due to the specific degeneration f the ganglion 
cell layer and the optic nerve; this focal pathology occurs 
despite the systemic presence of the mutation. The simple 
story, therefore, is that mitochondrial mutations can lead 
to optic nerve degeneration. This causal relationship is 
not surprising because of the high energy demands of the 
visual system and the key role of mitochondria n cellular 
energy production. It is emerging, however, that LHON 
is both more complex and more interesting than this 
simple story. The purpose of this review i~,; not only to 
summarize the genetic, biochemical, pathological, and 
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clinical studies that have been carried out on LHON 
patients, but also to discuss how systemic mitochondrial 
mutations might cause a focal neurodegeneration. 
Furthermore, emphasis is given to the similarities 
between LHON and other optic nerve degenerative 
disorders. 
PATHOGENIC MITOCHONDRIAL MUTATIONS IN 
LHON PATIENTS 
The identification of the mitochondrial gene mutations 
that are the primary causative factors in LHON has not 
been as straightforward as one might anticipate, given the 
plethora of well-documented LHON families and the 
small size of the mitochondrial genome (Brown & 
Wallace, 1994; Howell, 1994a, b). There are several fac- 
tors that have complicated the identification of patho- 
genic mutations in LHON patients: 
1. the rapid evolution of the mitochondrial genome 
results in extensive divergence so that, typically, 
pathogenic mutations are "hidden" within a back- 
ground of multiple sequence changes; 
2. the analysis of singleton cases and/or small families 
with bilateral optic atrophy raises the possibility that 
these are not "true" (viz. mitochondrial) LHON 
patients; 
3. similarly, families have been analyzed that have a 
LHON-like optic neuropathy and additional neuro- 
logical abnormalities; and 
4. the presence of mitochondrial mutations that may 
have a secondary etiological role. 
The mitochondrial genomes from numerous LHON 
families and patients have now been analyzed. One view 
is that there are many mitochondrial mutations, affecting 
different respiratory chain complexes, that have a 
primary or secondary pathogenic role. Thus, Brown and 
Wallace (1994) list 16 mitochondrial mutations asso- 
ciated with LHON (their Table 1). In opposition to this 
view, there is impressive vidence that the vast majority 
of LHON families carry one of only three primary 
pathogenic mutations, these occurring at nucleotides 
3460, 11 778, and 14484. These mutations result in 
amino acid substitutions in the ND1, ND4, and ND6 
genes, respectively, which are three of the seven 
mitochondrial genes that encode subunits of complex I 
of the respiratory chain (NADH-ubiquinone oxidoreduc- 
tase). As an example of this more conservative approach, 
David Mackey (Melbourne University) has been spear- 
heading a large collaborative ffort to identify the 
primary pathogenic mitochondrial mutations in LHON 
patients and their population frequencies. Analysis has 
been limited to families with the "classical" optic 
neuropathy (viz. not accompanied by additional neuro- 
logical or pathological bnormalities) and to those with 
multiple affected members in different generations, 
which should eliminate autosomal recessive or dominant 
optic atrophies. With these xclusion criteria, 159 LHON 
families (totaling over 11 000 members, >1500 of whom 
have been affected visually) from Northern Europe, the 
United Kingdom, and Australia were analyzed (Mackey 
et al., 1996). It was found that 153 families (96%) carried 
either the 3460 (21 families), the 11 778 (110 families), or 
the 14 484 (23 families) primary LHON mutation. Both 
Johns (1995) and Wallace (1995) continue to vouchsafe a 
pathogenic role for a mutation at nucleotide 15 257 that 
alters an amino acid residue of the protonmotive 
cytochrome b subunit of complex III (see the discussion 
in Howell, 1994a, b). However, none of the LHON 
families in this large survey carried the 1:5 257 mutation 
in isolation of one of the three primary mutations. At the 
present ime, therefore, it appears that the spectrum of 
primary LHON mutations may be narrow and that several 
of the putative primary mutations that were identified 
previously should be viewed with skepticism pending 
further analysis (Howell, 1994a, b). Although additional, 
rare primary LHON mutations will probably be identified 
[e.g. Howell et al. (1993b)], their significance should be 
"weighted" appropriately. Furthermore, and this may be a 
key point for pathophysiology, LHON may be caused 
only by mitochondrial mutations that affect complex I. 
Johns and Berman (1991) were the first investigators to 
propose that, in addition to primary mutations, there 
might be mitochondrial mutations that play a secondary 
role in the etiology and/or pathogenesis of LHON. In 
contrast to primary mutations, econdary mutations are 
found in normal controls, but at a lower frequency than in 
LHON patients. Additionally, they tend to produce more 
conservative amino acid changes and/or in less strin- 
gently conserved residues. Among Australian 11 778 
LHON families, the penetrance of the optic neuropathy 
was higher in those whose mitochondrial genomes carry 
secondary LHON mutations than in those who do not 
]Howell et al, (1993a); see also Johns (1994)]. This 
comparative approach is fraught with simplifying 
assumptions, however, and other studies have not 
supported a pathogenic effect of secondary mutations 
(Oostra et al., 1994; Nikoskelainen et al., 1996). 
Furthermore, we have recently shown that the increased 
frequency of secondary mutations in LHON patients can 
be explained solely in terms of population history and 
genetics (Howell et al., 1995). There is not yet an 
established pathogenic or etiological role for secondary 
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FIGURE 1. The optic neuropathy of LHON. The typical pathological 
changes that occur are shown for the three major sl~ages ofthe disorder. 
The severity ofthe changes and their timing are variable. 
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LHON mutations, and they may be benign polymorph- 
isms. 
It is one thing for mitochondrial geneticists to debate 
the pathogenic role of a putative LHON mutation, but 
where does this uncertainty leave clinicians when 
diagnosing patients with suspected LHON, and when 
counseling affected and unaffected family members? If a 
patient carries one of the three "canonical" mutations (at 
nucleotides 3460, 11 778, or 14484), of if there is a 
definite pattern of maternal inheritance but no identified 
mutation, then counseling is fairly straightforward. On 
the other hand, if maternal inheritance is dubious or 
uncertain, and/or if a rare, noncanonical LHON mutation 
has been found, then counseling and diagnosis hould 
reflect he uncertainty attached to such mutations. 
THE OPTIC NEUROPATHY IN LHON AND 
RECOVERY OF VISION 
The initial symptom during the acute phase of LHON 
(summarized in Fig. 1) is a blurring or clouding of vision 
in one eye, and then the other, that progresses, usually 
without pain, over a period of weeks to its nadir. The 
initial field defect is an enlargement of the blindspot that 
expands to an absolute central or cecocentral scotoma, 
often breaking through at the periphery. Dyschromatop- 
sia is invariably present and it may be the earliest 
indicator of optic nerve dysfunction (Miller, 1982). In 
approximately one half of those affected, both eyes are 
affected simultaneously although a delay of weeks or 
months is also common. Loss of visual acuity is typically 
severe and complete blindness can occur; one study, for 
example, found that the median final visual acuities were 
1/60 and 3/60 in LHON patients with the 11 778 and 3460 
primary mutations, respectively (Riordan-Eva et al., 
1995). Males and females appear to be affected to similar 
extents although affected women with the 11778 
mutation may have a more severe loss of vision 
(Riordan-Eva et al., 1995). The mean age of onset, for 
both sexes, is in the mid-twenties but the: range is 
remarkably broad, ranging from children under the age of 
10 yr to adults in their seventies. There is no discernable 
correlation among age of onset, the time to nadir, or 
extent of vision loss for patients with the 11 778 or 3460 
primary LHON mutations. The situation with regard to 
the 14484 mutation is more complicated and it will 
discussed further below. There are also LHON patients in 
which there is an atypical optical neuropathy including a 
slowly progressive presentation [e.g. Weiner et al. 
(1993); Swartz & Savino (1994); Nikoskelainen et al. 
(1996)]. A number of excellent reviews of the optic 
neuropathy in LHON patients have appeared in recent 
years and they should be consulted for details [e.g. Miller 
(1982); Newman et al. (1991); Johns (1994); Nikoske- 
lainen (1994); Sherman & Kleiner (1994); Riordan-Eva 
et al. (1995); Nikoskelainen et al. (1996)]. 
One of the most peculiar clinical features of LHON is 
the preservation of pupillary responses, even in those 
patients who have severe loss of central vision (Sherman 
& Kleiner, 1994; Nikoskelainen et al., 1996). Videopu- 
pillographic analysis by Wakakura nd Yokoe (1995) of 
12 patients with the 11 778 primary mutation and of one 
with the 14 484 primary mutation demonstrated that the 
pupillary responses were more intact han those measured 
in patients with idiopathic optic neuropathy or anterior 
ischaemic optic neuropathy, suggesting a preferential 
sparing of the W ganglion cells in LHON patients. 
Extensive fundoscopic data are available for presymp- 
tomatic or unaffected family members, and for affected 
individuals in the acute and atrophic phases [in particular, 
see Nikoskelainen (1994); Riordan-Eva et al. (1995)]. 
Particular attention has been paid to a peripapillary 
microangiopathy that was first described by Leber (1871) 
and that involves tortuous vessels in the central retina and 
telangiectatic capillaries. The microangiopathy is present 
in presymptomatic ndividuals and during the acute 
phase, where it is often more marked because of the 
dilation of the vessels and arteriovenous shunting, but it 
resolves during the atrophic phase. Fluorescein angio- 
graphy has shown that "leakage" from these tortuous 
vessels and retinal hemorrhages are rare (viz. the vascular 
endothelium is not compromised). Nikoskelainen (1994) 
asserts that dilation of the microangiopathic vessels 
signals imminent commencement of the acute phase and 
she has proposed that LHON is primarily an intraocular 
microvascular disorder. However, there is controversy 
over such a primary pathophysiological role for the 
microangiopathy (Newman et al., 1991; Riordan-Eva et 
al., 1995). 
Another early change during the acute phase is a 
pseudoedema of the nerve fiber layer and apparent 
hyperemia of the disk (van Senus, 1963; Nikoskelainen, 
1994). During the atrophic phase, the disk becomes pale; 
the peripapillary nerve fiber layer disappears, initially in 
the papillomacular bundle and then outside of this region. 
Miller (1982) has noted abnormality in the peripapillary 
nerve fiber layer in asymptomatic LHON family 
members but it was not ascertained if these individuals 
subsequently became visually affected. 
Vision loss in LHON patients is usually permanent, but 
a significant proportion of patients show objective 
improvement, sometimes to a dramatic degree. Recovery 
in 11 778 patients is rare; Johns (1994), for example, cites 
a frequency of 4%. In marked contrast, approximately 
one-half of all 14 484 LHON patients how improvement. 
Furthermore, the frequency of improvement is particu- 
larly high in those patients who lose vision before the age 
of 30 yr [reviewed in Mackey & Howell (1992); Johns 
(1994); Riordan-Eva et al. (1995)]. Recovery of vision in 
3460 LHON patients appears to have an intermediate 
frequency (Johns, 1994). There may be a further 
difference between 11778 and 14484 LHON patients. 
Recovery in the former often involves a small island of 
vision whereas there is noticeable shrinkage of the field 
defect in 14484 patients (Mackey & Howell, 1992; 
Hrynchak & Spaflord, 1994). Finally, recovery of vision 
may occur relatively soon after vision loss, or it may not 
be noticeable for several years. The recovery of vision in 
LHON patients indicates that this disorder cannot involve 
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an all-or-nothing neurodegeneration; nstead, at least in a 
large proportion of 14484 LHON patients, there are 
ganglion cells that reversibly lose function but avoid the 
cell death process for months or years. 
In addition to the optic neuropathy, there are numerous 
LHON family members in which there are also 
nonophthalmological abnormalities including peripheral 
neuropathy, CNS signs, and heart conduction defects 
[e.g. Newman et al. (1991); Nikoskelainen et al. (1995); 
Riordan-Eva et al. (1995)], a phenomenon that was first 
described by Leber (1871). In addition, LHON family 
members, usually females, reportedly have an increased 
risk of developing an MS-like condition (Flanigan & 
Johns, 1993; Riordan-Eva et al., 1995; Jansen et al., 
1996). These extra-ophthalmological abnormalities sug- 
gest that the neuropathology in LHON may be more 
diffuse and more varied than generally realized. At the 
present time, however, there is little else that can be noted 
other than their occurrence. 
An important exception to this general or "core" 
pattern is a group of families in which there is maternal 
inheritance of both a LHON-like optic neuropathy and 
relatively severe neurological bnormalities. For exam- 
ple, Wallace and coworkers have studied a "LHON plus 
dystonia" family in which a mutation at nucleotide 
14459 causes the disorder (Wallace, 1995). The 
proximity of this mutation to the primary LHON 
mutation at nucleotide 14484 is striking. The QLD1 
LHON family, in which there is also an array of severe 
neurological abnormalities (Wallace, 1970), is another 
example, but the etiology is different. In this family, the 
results indicate that the ophthalmological deficits are 
caused by the 14 484 primary LHON mutation whereas 
the neurological bnormalities appear to be caused by a 
second pathogenic mutation at nucleotide 4160 of the 
NDI gene (Howell, 1994a). De Vries et al. (1996) have 
recently suggested that mutations at nucleotides 11 696 
and 14596 are associated with a Dutch matrilineal 
pedigree in which LHON is combined with spastic 
dystonia. 
ELECTROPHYSIOLOGICAL TESTS IN LHON 
PATIENTS 
Electrophysiological studies of LHON patients have 
been comprehensively reviewed by Sherman and Kleiner 
(1994) and only a brief summary ispresented here. There 
is general agreement that flash electroretinograms (ERG) 
and electrooculograms (EOG) are normal in LHON 
patients, indicating functional integrity of the photo- 
receptors, bipolar cell layer, and retinal pigment 
epithelium. Riordan-Eva et al. (1995) reported that 3 of 
34 LHON patients had reduced "b" waves in their flash 
ERGs, perhaps representing retrograde transneuronal 
degeneration f preganglionic elements [see also Sadun 
et al. (1994)]. Integrity of visual evoked potentials 
(VEPs), which report he functional status of the maculus 
at the level of the occipital cortex, is a more complex 
issue. During the early acute phase, the VEPs become 
desynschronized, the amplitudes are decreased, and the 
latencies are prolonged. At the atrophic stage, it is 
generally observed that he VEPs are extinguished, which 
is expected because of the loss of ganglion cell function. 
However, there is conflicting evidence surrounding the 
timing of VEP abnormalities: ome inw~stigators have 
reported alterations in asymptomatic LHON family 
members whereas others conclude that the VEP abnorm- 
alities are synchronous with the loss of vi~sual cuity. 
Another test is the critical frequency of' photic driving 
(CFPD), the electrophysiological counterpart of the 
critical flicker fusion, which measures the highest 
frequency of photic driving to repetitive flash stimulation 
[discussed in Sherman & Kleiner (1994)]. CFPD 
frequencies are decreased in patients with demyelinating 
disorders but they were reported to be normal in one 
14 484 LHON patient, despite the presence of abnormal 
VEPs (Kothe et al., 1990). It is possible that normal 
CFPDs will be found in other LHON patients. However, 
it must be kept in mind that this patient's visual acuity 
loss was not severe, and that it subsequently showed 
marked improvement (Hrynchak & Spafford, 1994). 
There is a clear need for longitudinal e ectrophysiological 
testing of both affected and unaffected LHON family 
members to resolve these issues and to obtain informa- 
tion about he relative impairment of the magno (M) and 
parvo (P) pathways (Sherman & Kleiner, 1994). 
THE NEUROPATHOLOGY OF LHON 
In view of the interest in LHON, and its prevalence, it 
is surprising that there have been so few neuropatholo- 
gical studies. Furthermore, those studies that have been 
carded out have been seriously limited by two con- 
straints. In the first place, most of them involved patients 
in which the primary LHON mutation was not identified 
although apositive history of maternal transmission was 
noted in some cases. Moreover, there has been a 
tendency, perhaps unintentional, to study patients with 
accompanying eurological bnormalitie:~ [e.g. Kwittken 
& Barest (1958); Wilson (1963)], thereby raising the 
possibility that the findings do not reflect those to be 
found in more typical LHON patients. Secondly, 
neuropathological studies have been carried with patients 
who lost vision many years prior to death. Because there 
is no "hard" information about he kinetics of neurode- 
generation i LHON (see also the next section), itmay be 
risky to extrapolate he neuropathology at autopsy to that 
at the time of the acute phase. For example, the acute 
phase may signal the only (or major) wave or burst of 
optic nerve degeneration; i  this case, the final neuro- 
pathological status would be indicative of that at the 
beginning of the atrophic phase. On the other hand, the 
acute phase may only signal that crucial point in a long 
period of neurodegeneration when visual system failure 
was manifested. The tbrmer possibility seems the more 
likely because there is no trend for vision loss to progress 
during the atrophic phase. However, the recovery of 
vision in 14484 LHON patients is a salutary reminder 
that we must distinguish loss of vision from optic nerve 
degeneration. 
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These limitations notwithstanding, the neuropatholo- 
gical studies have consistently shown a degeneration of
the ganglion cell layer and of the optic nerve without any 
signs of an inflammatory process. For example, Kwittken 
and Barest (1958) have published what is probably the 
most complete pathological study of a putative LHON 
patient. This patient died of congestive heart failure 40 yr 
after losing vision at the age of 17 yr: with reference to 
the preceding discussion, it was remarked that his 
pupillary responses were still intact prior to death. The 
ganglion cell layer and optic nerve were atrophic with 
some degeneration i  the inner nuclear layer. There was 
some excavation of the disk, with glial and connective 
tissue filling, and there was also marked thickening of the 
glial septa in the optic nerve. Examination of the optic 
nerves, optic chiasm, and optic tracts revealed that axonal 
degeneration and demyelination occurred preferentially 
in the central regions, a finding that they noted was 
compatible with the loss of central vision. Furthermore, 
there was marked anterograde transneuronal degenera- 
tion in all six layers of the lateral geniculate bodies. This 
latter finding is particularly noteworthy because it argues 
against he suggestion that LHON involves preferential 
loss of the P ganglion cells (Rizzo, 1995). 
Finally, these investigators observed demyelination 
and gliosis in the gracilis columns of the spinal cord as 
well as some demyelination i the peripheral nerves of 
the lower extremities. They concluded that the peripheral 
neuropathy was unrelated to the optic neuropathy but, 
instead, was due to the patient's "malnutrition" (skeletal 
abnormalities were also present). However, the presence 
of peripheral neuropathy and skeletal abnonnalities in 
other LHON patients (see above) suggests that future 
neuropathological studies should further explore this 
issue. 
A genetically unconfirmed, singleton LHON case was 
described by de Gottrau et al. (1992). They noted atrophy 
of the ganglion cell layer and nerve fiber layer whereas 
the outer retinal layers were normal. The optic nerve, 
chiasma, optic tracts, and lateral geniculate nuclei were 
atrophic, more severely so in those regions connecting to 
the macular fibers. Furthermore, the dura mater and 
arachnoid of the optic nerve were markedly distended 
with considerable widening of the subarachnoid space. 
There are also CT and/or MRI findings of optic nerve 
distension in LHON patients (including some who carry 
the 11 778 primary mutation), sometimes appearing soon 
after the onset of the acute phase (Kermode et al., 1989; 
Smith et al., 1990). The usual interpretation of the 
distension is gliosis and/or edema: Wilson and Kline 
(1992) reported similar findings and the release of CSF 
during decompressive surgery. 
Sadun et al. (1994) reported the first neuropathological 
study of a genetically confirmed LHON patient: she 
carried the 11 778 primary mutation and she had suffered 
a rapid decline in vision to light projection 30 yr prior to 
death. The typical losses of the ganglion cell layer and 
nerve fiber layer were noted but there was also a mild loss 
of photoreceptors. There was no evidence for a marked 
inflammatory eaction and the histopathology was clearly 
different from that seen in MS-associated optic neuritis. It 
was particularly striking that there was an overall oss of 
95% of the axons in the optic nerve with some sparing in 
the naso-dorsal periphery. Furthermore, because the 
prechiasmal xon count was higher than that in the optic 
tract, they concluded that there may have been selective 
sparing of the optic nerve fibers that project to the 
perichiasmal structures. Such a pattern might explain 
retention of pupillary responses in affected LHON 
patients, but it raises the question of why these fibers 
are more resistant to neurodegeneration in LHON. 
Finally, these authors suggest that the abundance of 
debris in the optic nerve may represent the sequelae of a 
failure in axoplasmic transport. 
Finally, Kerrison et al. (1995) have recently published 
the neuropathology of a patient from the QLD 1 LHON 
family (see above), a woman who died at the age of 81 yr. 
There was the typical pattern of atrophy of the nerve fiber 
and ganglion cell layers without signs of inflammation. 
Within the optic nerve, there was a diffuse alxophy of the 
nerve fiber bundles, gliosis, demyelination, and thicken- 
ing of the pial septae. In contrast o some of the other 
studies, there was no marked sparing of fibers in the 
periphery of the optic nerve. Electron microscopy (EM) 
revealed that the remaining anglion cells were swollen 
and contained both swollen mitochondria nd double- 
membrane nclosed inclusions that had a high calcium 
content. The authors peculated that the calcium deposits 
may be related to an excitotoxic pathway of neurode- 
generation. Calcium deposits, or calcified nfitochondria, 
have not been reported in other studies of LHON patients, 
but this may simply reflect the paucity of EM studies. 
Alternatively, these findings may indicate that markedly 
abnormal calcium transport (and excitotoxicity) was 
causally associated with the 4160 mutation, rather than 
with the 14484 LHON mutation, although the histo- 
pathology of the retina and optic nerve was typical of 
LHON. 
RESPIRATORY CHAIN FUNCTION IN LHON 
PATIENTS AND THE BIOENERGETICS OF VISION 
The extent and nature of mitochondrial respiratory 
chain dysfunction in LHON patients is another con- 
troversial topic. Evidence for respiratory chain dysfunc- 
tion in 11 778 LHON patients has recently been obtained 
by Montagna et al. (1995) with 31P-NMR spectroscopy 
and serum lactate assays. However, biochemical assays 
of isolated mitochondria have yielded results that are 
more ambiguous. For example, Larsson et al. (1991) 
found no decrease in complex I specific activity (or in any 
other complex) in mitochondria isolated from affected 
and unaffected members of an 11 778 LHON family. 
However, when flux through the entire chain was assayed 
by measuring the rate of oxygen uptake with NADH- 
linked substrates, the rate was decreased to about one- 
half of that found in mitochondria from not:alal controls. 
In contrast, there was no decrease in flux with succinate 
as substrate, which enters the respiratory chain through 
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TABLE 1. Lactate:pyruvate ratios for primary fihroblast cultures 
Fibroblast Primary LHON 
culture mutations L:P ratio* 
L Normal controls 
2295 None 46.7 __+ 6.l (29)* 
2295/rotenone None 410.8 + 108.5 (9) 
1900 None 86.0 ___ 17.3 (12) 
1905 None 41.3 ___ 3.2 (12) 
0176 None 33.1 __. 1.1 (9) 
II. LHON patients 
1974 II  778 126.5 ___ 33.7 (9) 
2019 11778 92.1 ___ 21.2 (16) 
0310 3460 112.8 __+ 31.6 (12) 
0015 14484 121.8 _+ 14.2 (20) 
0171 14484 196.7 +__ 26.0 (7) 
0235 14484 207.5 _+ 33.6 (10) 
*Lactate and pyruvate release were measured after an incubation 
period of 6 hr. The experimental conditions were as follows: 
fibroblasts were plated at a density of ca 1.5 × 106 cells/10 cm petri 
dish in MEM medium (13% fetal calf serum). After an overnight 
incubation, the medium was aspirated, the dishes were rinsed once 
with medium, and then fresh medium was added. Rotenone was 
added to a final concentration of 1.0 #g/ml. 
tMean ___ 95% C.I. (number of assays). 
complex II. The authors concluded that the respiratory 
chain defect may lie in the interactions of the dehy- 
drogenases with complex I, rather than in electron 
transfer through the complex. Essentially the same 
results were obtained by Majander et al. (1991) in 
studies with EB-virus transformed lymphocytes. We 
have also confirmed that here is no decrease incomplex I 
specific activity in mitochondria from the WBC/platelet 
fraction of whole blood samples from 11 778 LHON 
patients (Bindoff et al., manuscript inpreparation). Smith 
et al. (1994) detected a small decrease (25%) in platelet 
mitochondrial complex I specific activity when non- 
smoking 11778 LHON patients were compared to 
nonsmoking controls, but no difference was found when 
smokers were included. Degli Esposti et al. (1994) have 
suggested that he 11 778 mutation reduces the "affinity of 
complex I for the ubiquinone substrate and increases 
resistance torotenone, a complex I inhibitor that probably 
functions as a quinone analog. Their interesting findings 
need confirmation. 
The recent work of Vergani et al. (1995) points the way 
to a potentially more powerful experimental pproach. 
They constructed cybrid lines in which mitochondria 
from control or 11 778 LHON patients, were transferred 
to cells that lack their own mtDNA (designated rho-zero 
lines). The 11778 primary LHON mutation caused 
decreased cellular respiration and lower mitochondrial 
complex I specific activity although the latter decrease 
was not statistically significant. Furthermore, they found 
that the presence of two secondary LHON mutations 
exacerbated the respiratory chain dysfunction. 
The results for the 3460 primary mutation have, thus 
far, been more clear-cut. In our initial studies (Howell et 
al., 1991), platelet mitochondria were isolated from both 
affected and unaffected 3460 LHON family members. 
When specific activities of the respiratory chain com- 
plexes were normalized to the specific activity of citrate 
synthase, another mitochondrially-locafized enzyme, 
there was an ca 80% reduction in complex I specific 
activity whereas there was no reduction in those of 
complex II or complex IV (cytochrome oxidase). Similar 
marked reductions were obtained in the studies of 
Majander et al. (1991) and of Smith et al. (1994). It is 
noteworthy that the complex I dysfunction was similarly 
severe in both affected and unaffected LHON family 
members, and in both males and females: this finding 
supports the inference from incomplete penetrance that 
the primary mutation is necessary--but insufficient--for 
the optic neuropathy. 
The effect of the 14 484 primary LHON mutation upon 
respiratory chain function has been particularly proble- 
matic. Parker et al. (1989) measured an ca 80% reduction 
in complex I specific activity in platelet mitochondria 
from QLD1 LHON patients; there were milder decreases 
in the activities of complexes II1 and IV, but these were 
not statistically significant. The interpretation of these 
results is complicated by the simultaneous presence of 
the 14 484 LHON and 4160 mutations. Cock et al. (1995) 
found no respiratory chain dysfunction in fibroblast 
mitochondria from 14 484 "only" LHON patients. Our 
preliminary results, however, indicate amarked complex 
I defect in 14 484 fibroblast mitochondria (Bindoff et al., 
manuscript in preparation). Furthermore;, Oostra et al. 
(1995), in assays with mitochondria from leucocytes of 
14484 LHON patients, also obtained evidence for a 
respiratory chain defect. They observed that complex I 
specific activity was reduced >50% when normalized to 
the level of citrate synthase or to complex IV but complex 
I-driven ATP synthesis was reduced only 20%. 
Our laboratory has taken a different tack to this 
problem. There are a number of technical problems that 
ensnare the unwary when one attempts to isolate 
mitochondria nd to then assay re,;piratory chain 
functions. In an effort to avoid these pitfalls, we have 
chosen to measure the release of lactate and pyruvate 
from intact, dividing fibroblasts. The lactate:pyruvate 
ratio is a sensitive indicator of the NADH/NAD balance 
and it will, in large part, be "set" physiologically by flux 
through the mitochondrial respiratory chain. When the 
respiratory chain is blocked, the NADH generated by the 
citric acid cycle and glycolysis accumulates and the 
lactate:pyruvate ratio increases. This approach has 
already been applied to fibroblasts from 11 778 LHON 
patients (Cornelissen et al., 1993), but the results were 
equivocal: increased ratios were found for some patients, 
but not for others. Their experiments seem to suffer from 
rather large variabilities and we have observed that the 
lactate:pyruvate ratio is exquisitely sensitive to the cell 
culture and incubation conditions (Howell et al., manu- 
script in preparation). Nevertheless, we have been able to 
obtain reasonable experimental variabilities and a sample 
of our results is shown in Table 1. These data indicate that 
there is a partial respiratory chain impairment, under 
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these experimental conditions, as a consequence of the 
3460, 11 778, and 14 484 primary LHON mutations. 
It is explicit in the OXPHOS (Wallace, 1995) and the 
ATP deficiency (Rizzo, 1995) hypotheses that LHON 
involves neurodegeneration f those cells (viz. retinal 
ganglion cells) that have the highest demand for 
mitochondrially-produced energy. One must treat these 
hypotheses with caution, however, because previous 
studies of the bioenergetics of vision do not indicate that 
ganglion cell function is markedly dependent upon 
mitochondrial energy production. In fact, it has been 
recognized for 40 yr that the photoreceptor layer of the 
retina is the richest in its content of the enzymes for 
oxidative metabolism (Lowry et al., 1956). In an elegant 
series of experiments, Ames et al. (1992) showed that 
phototransduction was supported by oxidative energy 
(generated by the mitochondria) whereas neurotransmis- 
sion through the inner retina was fueled almost 
exclusively by glycolysis. These investigators also found 
that about one-half of the oxidative nergy was consumed 
in processes that could not be identified although the 
active transport of calcium is one untested possibility. 
However, the studies of Ames et al. were relatively short- 
term and it may be that long-term viability or function of 
the ganglion cells has a high requirement for nfitochond- 
rially-produced energy. In this regard, axoplasmic 
transport has such a requirement [Ochs (1971); see also 
Hollander et al. (1995)]. Also, mitochondrial function is 
necessary to regenerate NAD from NADH; in other 
words, normal mitochondrial function may be necessary 
for maintaining the proper edox balance in the ganglion 
cells, rather than for ATP biosynthesis per  se. In this 
context, the fact that primary LHON mutations affect 
complex I subunits, and that this complex is the site of 
NADH reoxidation, appears much more than coinciden- 
tal. Finally, we must introduce the possible role of 
excitotoxicity, more of which is discussed in the 
subsequent sections. A number of studies have shown 
that reduced mitochondrial energy production leads to an 
activation of the NMDA-type glutamate receptors 
through relief of the voltage-dependent magnesium block 
[reviewed by Ludolph et al. (1993); Beal (1995)]. When 
the block is relieved, there is increased ion transport 
(particularly calcium) into the cells, ultimately resulting 
in cell death. 
INCOMPLETE PENETRANCE AND RISK FACTORS 
FOR MANIFEST BLINDNESS 
A feature of LHON that complicated early studies of its 
inheritance was its incomplete penetrance. Historically, it 
has been observed in large European LHON families that 
ca 50% of the males and 10% of the females developed 
the optic neuropathy (Bell, 1931; Lundsgard, 1944; van 
Senus, 1963; Seedorff, 1970; Nikoskelainen et al., 1987). 
More recent studies have separately analyzed LHON 
families according to their primary mutation [e.g. Johns 
(1994); Harding et al. (1995)], and there appear to be no 
substantial differences in penetrance among the different 
patient populations. For example, among Finnish LHON 
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FIGURE 2. Models for kinetics of neurodegeneration in LHON. (A) 
The threshold model in which the rate of ganglion cell degeneration is 
continuous and increased inLHON family members elative to normal 
individuals. The rate can be further increased by secondary factors 
(heavy tobacco use and/or alcohol consmuption, trauma, disease, tc.). 
(B) The "trigger" model in which a wave of neurodegeneration is 
triggered by the effects of the same secondary factors. 
patients, the penetrances are 39% (males)/14% (females) 
and 32% (males)/15% (females) for the 11 778 and 3460 
primary mutations, respectively [Nikoskelainen (1994), 
but see Black et al. (1995)]. 
The most important conclusion that has been drawn 
from incomplete penetrance is that the primary mutation 
is the major risk factor in LHON but that additional 
etiological factors are necessary. A great deal of effort 
has been expended to unravel the complex etiology of 
LHON, and several possible factors have been identified. 
In most LHON patients, the primary mutation is 
homoplasmic;  that is, every mtDNA molecule carries 
the mutant allele. However, in a small proportion of 
LHON patients (ca 15%), the primary mutation is 
heterop lasmic  and there are two populations of mito- 
chondrial DNA molecules, one carrying the wildtype 
allele and the other carrying the mutant allele [e.g. Smith 
et al. (1993); Ghosh et al. (1996)]. What can be safely 
asserted is that heteroplasmy of the primary mutation is 
not a major factor because there are large, well- 
characterized LHON families in which the primary 
mutation is homoplasmic and penetrance is incomplete. 
The marked isparity in penetrance between males and 
females within LHON families suggests an X-linked 
susceptibility locus that modifies pathophysiology. The 
initial experimental (Vilkki et al., 1991) and theoretical 
studies (Bu & Rotter, 1991) supported this possibility. 
More recent studies, however, have failed to locate such a 
locus (Carvalho et al., 1992; Sweeney et al., 1992; 
Juvonen et al., 1993; Mackey, 1993; Pegoraro et al., 
1996). Interest in this hypothesis continues as Harding et 
al. (1995) recently concluded that, within their LHON 
families, affected females had a higher incidence of 
affected offspring than did unaffected females. Resolu- 
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tion of this question may require separate analysis of 
LHON pedigrees according to primary mutation (Black 
et al., 1995). Alternatively, there may not be a single X- 
linked susceptibility locus and the disparity in penetrance 
may be polygenic in origin or due to diffuse physiological 
and/or anatomical differences between males and fe- 
males. 
There is considerable evidence that heavy alcohol and/ 
or tobacco use increases the risk of the optic neuropathy 
in LHON family members (Johns, 1994; Riordan-Eva et 
al., 1995). LHON family members have also lost vision 
shortly after head trauma (D. Mackey, personal commu- 
nication) or after extreme physical exertion (J. Sherman, 
personal communication). There is also the striking 
report of a young girl who carried the 11 778 primary 
mutation (DuBois & Feldon, 1992). At 9 yr of age, she 
simultaneously developed juvenile onset diabetes mellitis 
and optic neuropathy. Once her diabetes was controlled 
with insulin, her optic neuropathy improved. On the other 
hand, there are many LHON patients for whom no 
precipitating incident or chronic stress can be discerned. 
One of the difficulties in "pinning down" risk factors is 
that it is not clear when such factors may operate. Does 
one limit consideration ly to those events or conditions 
that occur within a few weeks prior to the onset of vision 
loss? A more complete and rigorous epidemiological 
analysis of LHON would provide much-needed informa- 
tion. 
Another complicating factor in this area is that the 
overall penetrance in Australian LHON families has 
decreased in recent generations (Mackey & Howell, 
1994). The incidence of affected males and females has 
decreased to about 20% and 4%, respectively (see also 
Table 3 of Harding et al., 1995), a trend that may reflect 
reduced environmental or dietary risk factors. 
These are uncharted waters, but some summarizing 
speculation may stimulate further theoretical considera- 
tion and experimental nalysis. There are two general 
models for the development of the optic neuropathy, 
which we may term the "threshold" and the "trigger" 
models (Fig. 2). In the first, there is a continuous rate of 
ganglion cell degeneration that is the cumulative product 
of several factors. In individuals who carry a primary 
LHON mutation, the rate of neurodegeneration would be 
increased and additional environmental nd lifestyle, 
genetic, and physiological (including normal aging) 
factors would further modify the rate. Once the extent 
of neurodegeneration exceeds a certain threshold, then 
the acute phase is initiated. The threshold model for 
mitochondrial diseases, including LHON, has been most 
persuasively argued by Wallace and coworkers [e.g. 
Brown et al. (1992); Wallace (1995)]. Alternatively, the 
primary LHON mutation may impair ganglion cell 
metabolism without producing substantially increased 
neuronal death. However, additional insults or conditions 
in these at-risk, more susceptible individuals would then 
"trigger" awave of neurodegeneration. The trigger model 
seems more compatible with the available data. 
THE DISK-AT-RISK AND LHON 
Burde (1993) has recently developed the "disk at risk" 
concept in which he identifies ome anatomical features 
that are common to several optic neuropathies including: 
1. LHON; 
2. nonarteritic anterior ischemic optic neuropathy; 
3. anterior ischemic optic neuropathy of the young; 
and 
4. the papillopathy in patients with juvenile-onset 
insulin-dependent diabetes mellitis. 
He does not include the toxic amblyopias, but in view 
of the evidence cited below, they would seem to be 
additional members of this group of optic nerve 
disorders. The anatomical features that characterize the 
"disk at risk" are a relatively small optic nerve head, 
absent or small cup, increased branching of the central 
retinal vessels within the disk, and a crowding or "heap- 
ing up" of the nerve fiber layer. He further postulates that 
the region in and around the lamina cribosa is particularly 
vulnerable to ischemia because vascularization is limited 
to the end arteries of the posterior ciliary circulation or 
the circumferential vessels of the circle of Zinn Haller. 
Burde envisages that these anatomical features lead to 
the optic neuropathy in LHON patients because the 
respiratory chain defect produces axoplasmic stasis and 
swelling, which in turn leads to further ,compression of 
the vessels and nerve fibers in this region, which then 
produces a more severe ischemia, ultimately causing an 
acute and major episode of neurodegene.ration. In their 
discussion of this concept, Sadun and Dao (1994) 
suggested another anatomical feature that contributes to 
the susceptibility ofthe optic disk. They point out that he 
axons of the optic nerve are sharply bent as they enter the 
laminosa cribosa and that there may be a higher energy 
demand for axoplasmic transport in this :region. Further- 
more, the septae of the lamina cribosa are more closely 
packed and thicker walled along the horizontal meridian 
of the optic nerve, which are the areas that "channel" the 
fibers that subserve the central and temporal portion of 
the visual field, the regions that are most commonly and 
most severely affected in LHON (Fechtner & Weinreb, 
1994). There is one final piece of anatomical evidence 
that supports the "disk at risk" concept and, particularly. 
its role as a factor in LHON. Electron microscopy of the: 
optic nerve reveals that here is a prominent accumulation 
of mitochondria ( nd other organelles) in the unmyeli- 
nated lengths of the prelamellar optic nerve axons as they 
transverse the lamina cribosa that may demarcate a zone 
of impaired or labile axoplasmic transport (Minckler et 
al., 1976; Hollander et al., 1995). 
Taken together, these results uggest that he optic disk 
and the optic nerve transversing the lamina cribosa are 
regions that might be particularly vulnerable, a "choke- 
point", to the consequences of mitochondrial dysfunc- 
tion. The prominent and early involvement of the 
papillomacular bundle during the acute phase, discussed 
previously, also supports this hypothesis',. 
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LHON AND OTHER BILATERAL OPTIC 
NEUROPATHIES 
In terms of the ophthalmological presentation, LHON 
is one of a group of bilateral optic neuropathies that 
includes the toxic amblyopias (also designated tobacco- 
alcohol or nutritional amblyopia). Adult-onset bilateral 
optic neuropathy is a relatively common problem, but the 
etiology remains to be identified in most cases, even 
when reasonable efforts are taken to exclude LHON and 
MS [e.g. Morrissey et al. (1995); Chan et al. (1996)]. 
Tobacco-alcohol amblyopia 
LHON is frequently misdiagnosed astobacco alcohol 
amblyopia [e.g. Cullom et al. (1993)]. Furthermore, there 
is a parallel decline in penetrance ofthe optic neuropathy 
in Australian LHON families and in the incidence of 
tobacco-alcohol amblyopia (Mackey & Howell, 1994), a 
result that suggests a common etiological factor. Rizzo 
(1995) has hypothesized that the common factor is a 
deficiency in mitochondrial ATP production. He further 
hypothesized that the P ganglion cells are particularly 
susceptible to ATP depletion because of their high firing 
rate, compared to that of M ganglion cells, aJad to their 
sustained action potentials. Rizzo (1995) also noted the 
possible role of vitamin B I2 deficiency as a causative 
factor in bilateral optic neuropathy. Golnik and Schaible 
(1994) have described a set of bilateral optic neuropathy 
patients with normal B12 levels but who were folate 
deficient. Treatment with folate resulted in improvement 
of visual acuity in these patients. These authors uggest 
that a deficiency of B12 or folate results in decreased 
tetrahydrofolate production, which--in turn---leads to 
decreased etoxification of formate and a chronic 
inhibition of mitochondrial cytochrome oxidase. 
An epidemic optic neuropathy, with an occasional 
peripheral neuropathy, affected >40000 Cubans in the 
early 1990s. Although a few "true" LHON patients were 
identified, a major etiological role for mitochondrial 
mutations was not substantiated and the principal 
causative factors appear to have been insufficient 
nutrition, heavy use of tobacco, and consumption of 
home-made rum, possibly contaminated with methanol 
(Hirano et al., 1994; Johns & Sadun, 1994; Johns et al., 
1994; Newman et al., 1994). 
Chloramphenicol optic neuropathy 
In the 1950s and 1960s, the antibiotic hloramphenicol 
was used to treat children with cystic fibrosis (Lloyd et 
al., 1963). However, it was soon reported that chlor- 
amphenicol treatment was associated with the develop- 
ment of an optic neuritis/optic atrophy, the incidence and 
severity of which was dose-dependent (Cocke et al., 
1966; Huang et al., 1966; Harley et al., 1970). In a 
presentation that was remarkably similar to that in LHON 
patients, there was a sudden onset, bilateral loss of central 
vision with the formation of central scotoma; papilloe- 
dema and pallor of the disk were also documented. 
Furthermore, it was commonly observed that there was 
an engorgement and tortuosity of the retinal veins with 
occasional retinal hemorrhage (Harley et al., 1970). 
Many of these optic neuritis/optic atrophy ]patients also 
had an accompanying peripheral neuropathy. In most 
cases, the vision deficit was corrected by :~topping the 
chloramphenicol and/or by multi-vitamin treatment 
including folate and B12. Neuropathological studies of 
five patients that had undergone long-term chloramphe- 
nicol treatment revealed egeneration in the ganglion cell 
layer, degeneration a d demyelination f the optic nerve 
(particularly in the papillomacular bundle), and gliosis of 
the nerve fiber layer (Table 3 of Harley et al., 1970). 
The use of the chloramphenicol in cystic fibrosis 
patients, and the study of the resulting optic neuritis/optic 
atrophy, were undertaken before it was recognized that 
this antibiotic is a specific inhibitor of rrtitochondrial 
protein synthesis. The retrospective interpretation of 
these results is that systemic application of an inhibitor of 
mitochondrial protein synthesis produced a selective 
ophthalmological pathology that was remarkably similar 
to LHON and one that was phenotypically reversible, at 
least to some extent, in terms of visual acuity. These 
results, therefore, provide the strongest and most direct 
evidence that the ganglion cell layer and optic nerve are 
exquisitely sensitive to the disruption of rnitochondrial 
biogenesis. 
LHON, GLAUCOMA, AND EXCITOTOXICITY 
A comparison of LHON with glaucoma reveals a 
relationship that merits further study. Electrophysiologi- 
cal and psychophysical tests of early stage glaucoma 
patients indicate a selective defect in the magnocellular 
channel that links the retina to the lateral geniculate 
nucleus (Bodis-Wollner, 1989). Neuropathological stu- 
dies confirm this pathway and report a selective 
degeneration f the M (or large) ganglion cells (Quigley 
et al., 1988; Wygnanski et al., 1995). 
In a recent review, Schumer and Podos (1994) have 
proposed that the neurodegeneration in glaucoma pro- 
ceeds through an excitotoxic "cascade" that involves 
persistent activation of NMDA receptors in the optic 
nerve, excessive calcium influx, increased nitric oxide 
synthesis, and production of oxygen free r~dicals. They 
develop an impressive argument. It is particularly 
striking that glutamate, an excitatory neurotransmitter, 
is more toxic to large ganglion cells, both in tissue culture 
of ganglion cells and in the intact rat (Dreyer et al., 1994). 
Furthermore, glatamate is elevated in the vitreous body of 
glaucoma patients (Dreyer et al., 1996). Excitotoxic 
neuronal death can occur through necrosis or apoptosis, 
depending upon the experimental conditions [e.g. Gwag 
et al. (1995)]. To add what may be the final step in the 
excitotoxic model, Quigley et al. (1995) have concluded 
that retinal ganglion cell death in experimental glaucoma 
occurs by apoptosis. 
Both glaucoma nd LHON (and other optic neuropa- 
thies) are similar disorders in that they result in 
degeneration f the ganglion cell layer and optic nerve. 
However, LHON and glaucoma clearly differ in their 
etiologies in which a respiratory chain dysfunction is
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identified as a major factor in LHON, and in the 
subpopulation(s) of retinal ganglion cells that are 
affected. Among the other notable similarities, there are 
indications in both that the region of the optic nerve as it 
transverses the lamina cribosa is a particularly vulnerable 
site [for glaucoma, see Fechtner & Weinreb (1994) and 
Quigley (1995)]. In this regard, cupping of the disk in 
LHON patients has been observed in several studies [e.g. 
Weiner et al. (1993) and references therein]. There is also 
evidence that an early event in glaucoma model systems 
is a defect in axoplasmic transport (Quigley, 1995). 
MODELS FOR LHON AND SOME CONCLUDING 
THOUGHTS 
What do we know about LHON? In some respects, as 
reviewed here, a great deal. In terms of which cells are 
dying and why, less so. Rizzo (1995) has hypothesized 
that LHON is one of a group of optic neuropathies that 
share an ATP deficiency which results in degeneration f
the P ganglion cells. Although an attractive hypothesis, 
the neuropathology suggests drop-out of both M and P 
ganglion cells in the central retina [e.g. Kwittken & 
Barest (1958)]. Riordan-Eva et al. (1995) have proposed 
a related but more detailed hypothesis. For example, they 
argue that the characteristic microangiopathy is a 
secondary, consequence of events that occur within the 
inner retina. They then extend the "disk at risk" concept 
and suggest that the LHON family members who become 
affected may have congenital crowding of the ganglion 
cell axons at the disk and in the peripapillary region. 
Finally, they contend that it is the small diameter nerve 
fibers in the central retina that degenerate during the 
acute phase. 
There is a lot to commend in the model of Riordan- 
Eva, particularly the postulate that subtle anatomical 
differences in the nerve fiber layer and disk have marked 
effects on the risk of vision loss. In addition, the structure 
of the lamina cribosa also appears to be important (Burde, 
1993). One may envisage that the primary LHON 
mutations produce a respiratory chain defect that, as its 
most direct effect for pathogenesis, compromises ax- 
oplasmic transport, particularly in the lamina cribosa 
"chokepoint" [cf Hollander et al. (1995)i]. As a 
consequence of further physiological stress and/or the 
anatomical features within an individual, local axoplas- 
mic transport slows to a level that precludes normal 
functioning of the ganglion cells [cf Sadun et al. (1994)]. 
There is evidence for individual variation in the density 
of the trabecular structural elements, a result that may 
define an important risk factor (Radius & Gonzales, 
1981; Quigley, 1995). The small diameter fibers are the 
most vulnerable to these noxious factors, but how this 
vulnerability is determined by the anatomical, metabolic, 
or neurochemical properties of the inner retina remains 
an important area for further investigation. A related 
question is to understand why some fibers are relatively 
refractory, such as those that control the pupillary 
response. 
It is at the stage of axoplasmic stasis that the 
biochemical signal for neurodegeneration can be trig- 
gered. In the case of the 11 778 primary" mutation, for 
reasons which are not yet clear, the "commitment to 
death" is made with only rare exception: the inactive 
ganglion cells die, possibly through an apoptotic path- 
way. This latter possibility would seem to be supported 
by the report hat retinal ganglion cells undergo apoptosis 
in anterior ischemic optic neuropathy (Levin & Louhab, 
1996). In the case of the 14484 primary mutation, the 
commitment to death is much less strong or less frequent 
with the consequence that, for prolonged periods of time, 
the ganglion cells are inactive but still viable. The 3460 
primary mutation apparently occupies the middle ground 
between these two extremes. If the hypothesis of 
axoplasmic stasis is correct, recovery of vision in 
14484 LHON patients might occur as the result of a 
small amount of neurodegeneration, thus relieving the 
anatomical block to axoplasmic transpor~t in the viable- 
but-inactive neurons. Although it is counter-intuitive, 
perhaps a little neurodegeneration can be a good thing! 
This suggestion also explains why the pe~ incidence of 
LHON is in the mid-twenties: starting in the second 
decade, there is a slow loss of foveal ganglion cells (Gao 
& Hollyfield, 1992), thus widening the anatomical 
chokepoint and commensurately diminishing the risk of 
vision loss. 
One possible explanation for the differences among 
primary LHON mutations, according to the hypothesis 
under consideration, is that while all of them impair 
respiratory chain function, they differ in thee production of 
free radicals at the level of complex I, a key factor in 
excitotoxicity/apoptosis pathways (Beal. 1995; Cui & 
Harvey, 1995; Wood & Youle, 1995). All, or almost all, 
retinal ganglion cells express NMDA receptors that are 
involved in synaptic transmission with cone bipolar cells 
[e.g. Hartveit et al. (1994)], and it is tempting to invoke 
an excitotoxic pathway. 
In summary, it has been the purpose here to review 
briefly what we know about LHON, and what we do not 
know. Molecular genetic diagnosis is on solid ground. 
Although a complete understanding of the complex 
etiology is lacking, several ikely risk factors have been 
proposed. We seem to be at the stage where we will start 
learning more about the cellular and biochemical path- 
ways leading to optic nerve degeneration. This progress 
will be important because it is from here that preventive 
or curative pharmacological intervention will come for 
LHON and, probably, for other optic nerve disorders as 
well. 
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